Hodgkin lymphoma patients typically present with lymphadenopathy that involves lymph node sites in a contiguous fashion, while extranodal sites of disease are less common. Systemic symptoms including fevers, drenching night sweats, weight loss, and pruritus may be present at diagnosis. A comprehensive ...
Also, while Hodgkin's disease is curable, regardless of stage, only certain histologic types of non-Hodgkin's lymphoma — primarily the lymphomas included in the category diffuse histiocytic lymphoma (DHL) — are curable when the disease is disseminated....
D. et al. Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial. Blood 133, 1964–1976 (2019). Article CAS PubMed PubMed Central Google Scholar Pan, R. et al. Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute ...
Non-Hodgkin’s lymphomaNon-Hodgkin's lymphomaRituximabBackground: The involvement of certain organs such as the adrenal gland and ovaries is rare in non-Hodgkin鈥檚 lymphoma (NHL). There are few studies comparing clinical features and prognosis based on the extranodal organ involved. Methods: We ...
A lymphoma diagnosis can be overwhelming. Lymphoma clinical trials can give you access to the latest treatment and advance cancer research.
- 1995 - A467 - www.sciencedirect.comdoi:10.1016/0016-5085(95)26182-6None
Hodgkin Lymphoma at the Paediatric Oncology Unit of Gabriel Touré Teaching Hospital, Bamako, Mali: 5-Year Experience Introduction. The aim of this retrospective, unicentric study over 5 years is to describe the epidemiologic, pathologic, clinic and therapeutic aspects of ... B Togo,F Traoré,AP...
non-Hodgkin lymphomapathologysurvivalThailandSystemic reports on the descriptive epidemiology of non‐Hodgkin lymphoma (NHL) from Southeast Asia are scarce. A nationwide multi‐institutional registry was conducted to compare the histopathology, clinical features, and survival of Thai adult patients with NHL...
Ten patients with previously untreated stage III/IV low grade histology non-Hodgkin's lymphoma received a 1-hour intravenous infusion of Didemnin B 2.3 mg/... G Goss,A Muldal,R Lohmann,... - 《Investigational New Drugs》 被引量: 167发表: 1995年 Pathologic and clinical features of 77 Hod...
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically aggressive in nature. These cancers remain difficult to treat and treatment can cause severe, long-term side effects. For patients who are not cured by su